Chemotherapy of cervix cancer with mitolactol (dibromodulcitol, NSC 104800) and cisplatin: A Phase I study of the Gynecologic Oncology Group

G. A. Omura, J. L. Hubbard, K. D. Hatch, J. B. Schlaerth, J. A. Blessing

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Chemotherapy of cervix cancer with mitolactol (dibromodulcitol, NSC 104800) and cisplatin: A Phase I study of the Gynecologic Oncology Group'. Together they form a unique fingerprint.

Medicine & Life Sciences